Oaktree Acquisition Corp. III Life Sciences (OACC) Competitors $10.50 -0.01 (-0.10%) As of 11:27 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OACC vs. FBRT, PBT, GETY, NXRT, NOAH, BRSP, TRTX, AACT, VINP, and ACShould you be buying Oaktree Acquisition Corp. III Life Sciences stock or one of its competitors? The main competitors of Oaktree Acquisition Corp. III Life Sciences include Franklin BSP Realty Trust (FBRT), Permian Basin Royalty Trust (PBT), Getty Images (GETY), NexPoint Residential Trust (NXRT), Noah (NOAH), BrightSpire Capital (BRSP), TPG RE Finance Trust (TRTX), Ares Acquisition Corporation II (AACT), Vinci Compass Investments (VINP), and Associated Capital Group (AC). These companies are all part of the "trading" industry. Oaktree Acquisition Corp. III Life Sciences vs. Its Competitors Franklin BSP Realty Trust Permian Basin Royalty Trust Getty Images NexPoint Residential Trust Noah BrightSpire Capital TPG RE Finance Trust Ares Acquisition Corporation II Vinci Compass Investments Associated Capital Group Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Franklin BSP Realty Trust (NYSE:FBRT) are both small-cap trading companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and profitability. Which has higher earnings and valuation, OACC or FBRT? Franklin BSP Realty Trust has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AFranklin BSP Realty Trust$210.45M4.40$95.88M$0.9811.49 Do analysts recommend OACC or FBRT? Franklin BSP Realty Trust has a consensus target price of $14.67, indicating a potential upside of 30.20%. Given Franklin BSP Realty Trust's stronger consensus rating and higher probable upside, analysts clearly believe Franklin BSP Realty Trust is more favorable than Oaktree Acquisition Corp. III Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oaktree Acquisition Corp. III Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Franklin BSP Realty Trust 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Is OACC or FBRT more profitable? Franklin BSP Realty Trust has a net margin of 53.36% compared to Oaktree Acquisition Corp. III Life Sciences' net margin of 0.00%. Franklin BSP Realty Trust's return on equity of 7.26% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A Franklin BSP Realty Trust 53.36%7.26%1.54% Do institutionals and insiders believe in OACC or FBRT? 59.9% of Franklin BSP Realty Trust shares are held by institutional investors. 1.4% of Franklin BSP Realty Trust shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media refer more to OACC or FBRT? In the previous week, Franklin BSP Realty Trust had 2 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 3 mentions for Franklin BSP Realty Trust and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 1.89 beat Franklin BSP Realty Trust's score of 0.62 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media. Company Overall Sentiment Oaktree Acquisition Corp. III Life Sciences Very Positive Franklin BSP Realty Trust Positive SummaryFranklin BSP Realty Trust beats Oaktree Acquisition Corp. III Life Sciences on 11 of the 12 factors compared between the two stocks. Get Oaktree Acquisition Corp. III Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for OACC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OACC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OACC vs. The Competition Export to ExcelMetricOaktree Acquisition Corp. III Life SciencesInvestment Offices IndustryFinancial SectorNASDAQ ExchangeMarket Cap$235.41M$195.78M$6.38B$10.26BDividend YieldN/AN/A4.33%4.61%P/E RatioN/AN/A1,781.7526.05Price / SalesN/AN/A1,347.73168.79Price / CashN/A37,149.00127.9261.52Price / BookN/AN/A2.076.29Net IncomeN/A-$160K$1.23B$270.94M7 Day Performance0.19%0.97%0.29%-0.30%1 Month Performance0.67%1.33%1.96%6.20%1 Year PerformanceN/A7.13%32.94%28.32% Oaktree Acquisition Corp. III Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OACCOaktree Acquisition Corp. III Life SciencesN/A$10.50-0.1%N/AN/A$235.41MN/A0.00N/APositive NewsFBRTFranklin BSP Realty Trust3.7504 of 5 stars$11.26-0.5%$14.67+30.3%-16.9%$931.35M$210.45M11.49N/AHigh Trading VolumePBTPermian Basin Royalty Trust1.1631 of 5 stars$17.76-2.5%N/A+58.0%$849.21M$26.96M49.33N/APositive NewsDividend IncreaseGETYGetty Images2.7611 of 5 stars$2.06+1.0%$4.03+95.4%-46.5%$846.22M$939.29M-7.361,700News CoverageHigh Trading VolumeNXRTNexPoint Residential Trust4.2541 of 5 stars$32.81+0.8%$40.88+24.6%-29.0%$825.36M$259.70M-16.743Positive NewsHigh Trading VolumeNOAHNoah3.5581 of 5 stars$11.64-1.4%$12.00+3.1%+15.7%$781.30M$356.33M10.391,990Dividend CutBRSPBrightSpire Capital2.7289 of 5 stars$5.81+0.6%$6.79+17.0%-3.7%$750.07M$244.77M-26.3950High Trading VolumeTRTXTPG RE Finance Trust2.6688 of 5 stars$9.24-1.1%$9.50+2.9%+1.9%$734.04M$351.97M14.21N/APositive NewsHigh Trading VolumeAACTAres Acquisition Corporation IIN/A$11.09-2.8%N/A-11.7%$705.20MN/A0.00N/ANews CoverageGap UpVINPVinci Compass Investments4.4588 of 5 stars$10.45+1.2%$13.50+29.2%+9.0%$661.60M$111.41M22.23240Positive NewsHigh Trading VolumeACAssociated Capital Group1.7191 of 5 stars$31.00-7.1%N/A-10.0%$653.91M$11.91M12.2520Negative NewsHigh Trading Volume Related Companies and Tools Related Companies Franklin BSP Realty Trust Competitors Permian Basin Royalty Trust Competitors Getty Images Competitors NexPoint Residential Trust Competitors Noah Competitors BrightSpire Capital Competitors TPG RE Finance Trust Competitors Ares Acquisition Corporation II Competitors Vinci Compass Investments Competitors Associated Capital Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OACC) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. III Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition Corp. III Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.